During the past decade, Louisiana State University Hospital - Shreveport conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Louisiana State University Hospital - Shreveport" #1 sponsor was "SWOG Cancer Research Network" with 8 trials, followed by "Eastern Cooperative Oncology Group" with 2 trials sponsored, "Matrix Pharmaceutical" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "PhaseBio Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Louisiana State University Hospital - Shreveport" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "North Central Cancer Treatment Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Louisiana State University Hospital - Shreveport" are "Lung Cancer" (3 trials), "Head and Neck Cancer" (2 trials), "Lymphoma" (2 trials), "Adrenocortical Carcinoma" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Louisiana State University Hospital - Shreveport" in a lesser frequency.

Most popular intervention types in "Louisiana State University Hospital - Shreveport" are "Drug" (12 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (4 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "carboplatin" (2 trials) and "cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Louisiana State University Hospital - Shreveport" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Louisiana State University Hospital - Shreveport". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Louisiana State University Hospital - Shreveport, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Louisiana State University Hospital - Shreveport, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Louisiana State University Hospital - Shreveport has several departments that took part in Clinical trials: "Ochsner LSU Health Shreveport - Regional Urology" - 4 trials